{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:37:46Z","timestamp":1789018666728,"version":"build-2803163510"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.schres.2025.04.023","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T12:21:21Z","timestamp":1745065281000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["CBT for psychosis in Parkinson's disease: A framework for how and why"],"prefix":"10.1016","volume":"280","author":[{"given":"Jennifer A.","family":"Foley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaughan","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2025.04.023_bb0005","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/gps.389","article-title":"A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson\u2019s disease with and without dementia","volume":"16","author":"Aarsland","year":"2001","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0010","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/schbul\/sbp148","article-title":"How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association","volume":"37","author":"Achim","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2025.04.023_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41537-022-00237-9","article-title":"Early-stage visual perception impairment in schizophrenia, bottom-up and back again","volume":"21","author":"Ad\u00e1mek","year":"2022","journal-title":"Schizophrenia"},{"key":"10.1016\/j.schres.2025.04.023_bb0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JPD-181462","article-title":"Shame in Parkinson\u2019s disease: A review","volume":"9","author":"Angulo","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.schres.2025.04.023_bb0025","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awp068","article-title":"The retina in Parkinson\u2019s disease","volume":"132","author":"Archibald","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.schres.2025.04.023_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2011.03.004","article-title":"Retinal thickness in Parkinson\u2019s disease","author":"Archibald","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jnnp.2007.116202","article-title":"Executive functions are impaired in Parkinson\u2019s disease with visual hallucinations","volume":"79","author":"Barnes","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0028-3932(02)00182-3","article-title":"Reality monitoring and visual hallucinations in Parkinson\u2019s disease","volume":"41","author":"Barnes","year":"2003","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.schres.2025.04.023_bb0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/jnp.12016","article-title":"Behavioural coping patterns in Parkinson\u2019s patients with visual hallucinations","volume":"7","author":"Barnes","year":"2013","journal-title":"J. Neuropsychol."},{"key":"10.1016\/j.schres.2025.04.023_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2020.101929","volume":"82","author":"Barnicot","year":"2020","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.schres.2025.04.023_bb0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jns.2009.08.022","article-title":"Nonmotor fluctuations in Parkinson\u2019s disease: clinical spectrum and classification","volume":"289","author":"Bayulkem","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.schres.2025.04.023_bb0060","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1007\/s00415-022-11074-2","article-title":"Two-year longitudinal follow-up of visual illusions and hallucinations in Parkinson\u2019s disease","volume":"269","author":"Beze","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.schres.2025.04.023_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/01.WNL.0000103444.45882.D8","article-title":"Opthalmologic features of Parkinson\u2019s disease","volume":"62","author":"Biousse","year":"2004","journal-title":"Neurol"},{"key":"10.1016\/j.schres.2025.04.023_bb0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1192\/bjp.bp.109.074526","article-title":"Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review","volume":"197","author":"Bird","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0075","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.26643","article-title":"Prevalence of anxiety in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"31","author":"Broen","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0080","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jnnp.2010.213652","article-title":"Depression and anxiety related subtypes in Parkinson\u2019s disease","volume":"82","author":"Brown","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jnnp-2012-304095","article-title":"Clinical and cognitive correlates of visual hallucinations in dementia with Lewy bodies","volume":"84","author":"Cagnin","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1192\/bjp.164.2.190","article-title":"The omnipotence of voices. A cognitive approach to auditory hallucinations","volume":"164","author":"Chadwick","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2023.102303","article-title":"Delusions and the dilemmas of life: A systematic review and meta-analyses of the global literature on the prevalence of delusional themes in clinical groups","volume":"104","author":"Collin","year":"2023","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.schres.2025.04.023_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104749","article-title":"Prevalence and clinical aspects of depression in Parkinson\u2019s disease: a systematic review and meta-analysis of 129 studies","volume":"141","author":"Cong","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.schres.2025.04.023_bb0105","doi-asserted-by":"crossref","DOI":"10.53841\/bpsneur.2020.1.10.47","article-title":"Distress associated with recurrent complex visual hallucinations in dementia with Lewy bodies: the application of adapted cognitive behavioural therapy (CBT)","volume":"1","author":"Cook","year":"2022","journal-title":"The Neuropsychologist."},{"key":"10.1016\/j.schres.2025.04.023_bb0110","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cercor\/11.12.1136","article-title":"Enhanced or impaired cognitive function in Parkinson\u2019s disease as a function of dopaminergic medication and task demands","volume":"11","author":"Cools","year":"2001","journal-title":"Cereb. Cortex"},{"issue":"9","key":"10.1016\/j.schres.2025.04.023_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291357","article-title":"Exploring public perceptions and awareness of Parkinson\u2019s disease: A scoping review","volume":"18","author":"Crooks","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2025.04.023_bb0120","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.visres.2004.11.006","article-title":"Visual and spatial symptoms in Parkinson\u2019s disease","volume":"45","author":"Davidsdottir","year":"2005","journal-title":"Vis. Res."},{"key":"10.1016\/j.schres.2025.04.023_bb0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.parkreldis.2021.12.013","article-title":"\u201cAccidental, really?\u201d attributional bias in patients with Parkinson\u2019s disease","volume":"95","author":"Decombe","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mdc3.13104","article-title":"Increasing contrast improves object perception in Parkinson\u2019s disease with visual hallucinations","volume":"8","author":"D\u00edaz-Santos","year":"2020","journal-title":"Mov. Disord Clin. Pract."},{"key":"10.1016\/j.schres.2025.04.023_bb0135","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mds.10450","article-title":"Coping strategies for visual hallucinations in Parkinson\u2019s disease","volume":"18","author":"Diederich","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","article-title":"Hallucinations in Parkinson disease","volume":"5","author":"Diederich","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.schres.2025.04.023_bb0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/07317115.2016.1240131","article-title":"Cognitive behavior therapy for anxiety in Parkinson\u2019s disease: outcomes for patients and caregivers","volume":"40","author":"Dissanayaka","year":"2017","journal-title":"Clin. Gerontol."},{"key":"10.1016\/j.schres.2025.04.023_bb0150","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/mds.21455","article-title":"Cognitive-behavioural therapy for depression in Parkinson\u2019s disease: a pilot study","volume":"22","author":"Dobkin","year":"2007","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.schres.2025.04.023_bb0155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1037\/a0027695","article-title":"Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease","volume":"80","author":"Dobkin","year":"2012","journal-title":"J. Consult. Clin. Psych."},{"key":"10.1016\/j.schres.2025.04.023_bb0160","doi-asserted-by":"crossref","unstructured":"Dobson, D. J. G., Dobson, K. S., 2018. Avoidance in the clinic: strategies to conceptualize and reduce avoidant thoughts, emotions, and behaviours with cognitive-behavioural therapy. Pract. Innov. 3, 32\u201342. https:\/\/psycnet.apa.org\/doi\/10.1037\/pri0000061.","DOI":"10.1037\/pri0000061"},{"key":"10.1016\/j.schres.2025.04.023_bb0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1531-8257(200101)16:1<135::AID-MDS1006>3.0.CO;2-Q","article-title":"Clozapine for the treatment of drug-induced psychosis in Parkinson\u2019s disease: results of the 12-week open label extension in the PSYCLOPS trial","volume":"16","author":"Factor","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0170","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jns.2014.10.033","article-title":"Cognitive correlates of hallucinations and delusions in Parkinson\u2019s disease","volume":"347","author":"Factor","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.schres.2025.04.023_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mdc3.12381","article-title":"Affective correlates of psychosis in Parkinson\u2019s disease","volume":"4","author":"Factor","year":"2017","journal-title":"Mov. Disord Clin. Pract."},{"key":"10.1016\/j.schres.2025.04.023_bb0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","article-title":"Epidemiology of psychosis in Parkinson\u2019s disease","volume":"289","author":"F\u00e9nelon","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.schres.2025.04.023_bb0185","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.schres.2025.04.023_bb0190","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jnnp.2010.234799","article-title":"Feeling of presence in Parkinson\u2019s disease","volume":"82","author":"F\u00e9nelon","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0195","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/bs.irn.2017.04.005","article-title":"Psychosis in Parkinson\u2019s disease","volume":"133","author":"ffytche","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.schres.2025.04.023_bb0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","article-title":"The psychosis spectrum in Parkinson\u2019s disease","volume":"13","author":"ffytche","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.schres.2025.04.023_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105805","article-title":"Prevalence and impact of mental health issues in Parkinson\u2019s disease unplanned hospital admissions","volume":"115","author":"Foley","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0210","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cortex.2017.08.009","article-title":"The neuropsychological profile of Othello syndrome in Parkinson\u2019s disease","volume":"96","author":"Foley","year":"2017","journal-title":"Cortex"},{"key":"10.1016\/j.schres.2025.04.023_bb0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/13546805.2023.2229080","article-title":"A Bayesian predictive processing account of Othello syndrome in Parkinson\u2019s disease","volume":"28","author":"Foley","year":"2023","journal-title":"Cogn. Neuropsychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0220","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.0b013e3181f61311","article-title":"What predicts mortality in Parkinson disease? A prospective population-based long-term study","volume":"75","author":"Forsaa","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.schres.2025.04.023_bb0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/09638239818175","article-title":"Cognitive therapy for psychosis: formulation, treatment, effects and service implications","volume":"7","author":"Fowler","year":"1998","journal-title":"J. Ment. Health"},{"issue":"5 Suppl","key":"10.1016\/j.schres.2025.04.023_bb0230","first-page":"S83","article-title":"Parkinson\u2019s disease and Parkinson\u2019s disease psychosis: a perspective on the challenges, treatments, and economic burden","volume":"23","author":"Fredericks","year":"2017","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.schres.2025.04.023_bb0235","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2215-0366(16)00066-3","article-title":"Persecutory delusions: A cognitive perspective on understanding and treatment","volume":"3","author":"Freeman","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0240","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S2215-0366(23)00257-2","volume":"10","author":"Freeman","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S0033291701003312","article-title":"A cognitive model of the positive symptoms of psychosis","volume":"31","author":"Garety","year":"2001","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2025.04.023_bb0250","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/gps.3869","article-title":"Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson\u2019s disease: a longitudinal 4-year study","volume":"28","author":"Gibson","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0255","first-page":"713","article-title":"The malignant course of \u2018benign hallucinations\u2019 in Parkinson\u2019s disease","volume":"63","author":"Goetz","year":"2006","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.schres.2025.04.023_bb0260","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.parkreldis.2010.08.007","article-title":"Dopamine agonists and Othello syndrome","volume":"16","author":"Graff-Radford","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0265","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/JGP.0b013e31823033bc","article-title":"Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy bodies","volume":"20","author":"Hamilton","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1192\/bjp.bp.112.112300","article-title":"Cost-effectiveness of early intervention in first-episode psychosis: economic evaluation of a randomised controlled trial (the OPUS study)","volume":"202","author":"Hastrup","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0275","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/jnnp.70.6.734","article-title":"Prospective study of hallucinations and delusions in Parkinson\u2019s disease","volume":"70","author":"Holroyd","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0280","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp.2009.179655","article-title":"Differential progression of brain atrophy in Parkinson\u2019s disease with and without visual hallucinations","volume":"81","author":"Ibarretxe-Bilbao","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0285","article-title":"An evaluation of UK psychological services for people with Parkinson\u2019s disease: current practice and recommendations for improvement","volume":"18","author":"Ihnen","year":"2024","journal-title":"The Neuropsychologist."},{"key":"10.1016\/j.schres.2025.04.023_bb0290","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/14656566.2025.2481205","article-title":"Management of Parkinson\u2019s disease psychosis: first-line antipsychotic selection and rationale for continuing, combining, or switching","volume":"26","author":"Isaacson","year":"2025","journal-title":"Expert Opin. Pharamother."},{"key":"10.1016\/j.schres.2025.04.023_bb0295","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2016.12.063","article-title":"Knowledge, attitudes and perceptions of Parkinson\u2019s disease: A cross-sectional survey of Asian patients","volume":"374","author":"Jitkrtisadakul","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.schres.2025.04.023_bb0300","first-page":"121","volume":"63","author":"Kingsep","year":"2003","journal-title":"Cognitive behavioural group treatment for social anxiety in schizophrenia."},{"key":"10.1016\/j.schres.2025.04.023_bb0305","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00702-009-0302-1","article-title":"Admission of parkinsonian patients to a neurological ward in a community hospital","volume":"116","author":"Klein","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.schres.2025.04.023_bb0310","first-page":"15","article-title":"Cognitive-behavioural therapy for non-motor symptoms of Parkinson\u2019s disease: a clinical review","volume":"20","author":"Koychev","year":"2017","journal-title":"BMJ Ment. Health."},{"key":"10.1016\/j.schres.2025.04.023_bb0315","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1017\/S1121189X00002153","article-title":"Cognitive behavioural therapy for psychosis","volume":"15","author":"Kuipers","year":"2011","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.schres.2025.04.023_bb0320","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1017\/S1352465815000727","article-title":"Visual hallucinations in older people: appraisals but not content or phenomenology influence distress","volume":"44","author":"Lai","year":"2016","journal-title":"Behav. Cogn. Psychother."},{"issue":"1","key":"10.1016\/j.schres.2025.04.023_bb0325","article-title":"An overview of the evidence for psychological interventions for psychosis: results from meta-analyses. Clin psych","volume":"1","author":"Lincoln","year":"2019","journal-title":"Europe"},{"issue":"1","key":"10.1016\/j.schres.2025.04.023_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278262","article-title":"Assessing the risks of treatment in Parkinson disease psychosis: an in-depth analysis","volume":"18","author":"Longardner","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2025.04.023_bb0335","doi-asserted-by":"crossref","unstructured":"Marsh, L., Williams, J. R., Rocco, M., Grill, S., Munro, C., Dawson, T. M.k 2004. Psychiatric comorbidities in patients with Parkinson's disease and psychosis. Neurol 63, 293\u2013300. doi:https:\/\/doi.org\/10.1212\/01.wnl.0000129843.15756.a3.","DOI":"10.1212\/01.WNL.0000129843.15756.A3"},{"key":"10.1016\/j.schres.2025.04.023_bb0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2007.05.009","article-title":"A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson\u2019s disease patients without dementia","volume":"14","author":"McKinlay","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0345","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/13607860802343225","article-title":"Neuropsychiatric problems in Parkinson\u2019s disease: comparisons between self and caregiver report","volume":"12","author":"McKinlay","year":"2008","journal-title":"Aging Ment. Health"},{"key":"10.1016\/j.schres.2025.04.023_bb0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S0033291712001146","article-title":"Social anxiety disorder and shame cognitions in psychosis","volume":"43","author":"Michail","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2025.04.023_bb0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/brainsci7050045","article-title":"Systematic review of cognitive-behavioural therapy for social anxiety disorder in psychosis","volume":"7","author":"Michail","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.schres.2025.04.023_bb0360","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/mds.28533","article-title":"Cognitive behavioral therapy for anxiety in Parkinson\u02bcs disease: a randomized controlled trial","volume":"36","author":"Moonen","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0365","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jnnp-2011-300043","article-title":"Psychosis associated to Parkinson\u2019s disease in the early stages: relevance of cognitive decline and depression","volume":"83","author":"Morgante","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0370","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archneur.57.4.489","article-title":"Visuoperceptual impairment in dementia with Lewy bodies","volume":"57","author":"Mori","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.schres.2025.04.023_bb0375","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1212\/01.WNL.0000145764.70698.4E","article-title":"Visual perception in Parkinson disease dementia and dementia with Lewy bodies","volume":"63","author":"Mosimann","year":"2004","journal-title":"Neurol"},{"key":"10.1016\/j.schres.2025.04.023_bb0380","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.schres.2025.04.023_bb0385","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.schres.2025.04.023_bb0390","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.schres.2025.04.023_bb0395","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.parkreldis.2018.05.023","article-title":"Defining visual illusions in Parkinson\u2019s disease: Kinetopsia and object misidentification illusions","volume":"55","author":"Nishio","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0400","first-page":"680","article-title":"Visual hallucinations are characterized by impaired sensory evidence accumulation: insights from hierarchical drift diffusion modeling in Parkinson\u2019s disease","volume":"2","author":"O\u2019Callaghan","year":"2017","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging."},{"key":"10.1016\/j.schres.2025.04.023_bb0405","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/mds.20582","article-title":"Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson\u2019s disease","volume":"20","author":"Pachetti","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0410","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/mds.21864","article-title":"A prospective study of delusional misidentification syndromes in Parkinson\u2019s disease with dementia","volume":"23","author":"Pagonabarraga","year":"2008","journal-title":"Mov Cisord."},{"key":"10.1016\/j.schres.2025.04.023_bb0415","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26432","article-title":"Minor hallucinations occur in drug-naive Parkinson\u2019s disease patients, even from the premotor phase","volume":"31","author":"Pagonabarraga","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0420","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-023-00918-8","article-title":"Parkinson disease psychosis: from phenomenology to neurobiological mechanisms","volume":"20","author":"Pagonabarraga","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.schres.2025.04.023_bb0425","unstructured":"Parkinson's UK, 2021. Nobody really knows us: The state of health and social care for people with Parkinson's-related dementia. https:\/\/www.parkinsons.org.uk\/sites\/default\/files\/2021-11\/PUK0973_Dementia%20policy%20report_CS3739_web_SIGN%20OFF.pdf."},{"issue":"5","key":"10.1016\/j.schres.2025.04.023_bb0430","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jnnp.2003.029868","article-title":"Clozapine in drug induced psychosis in Parkinson\u2019s disease: a randomised, placebo controlled study with open follow up","volume":"75","author":"Pollak","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0435","volume":"38","author":"Puntambekar","year":"2023","journal-title":"Neurpsychological correlates of visual hallucinatory phenomena in Lewy body disease."},{"key":"10.1016\/j.schres.2025.04.023_bb0440","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000100850","article-title":"Cognitive changes in Parkinson\u2019s disease patients with visual hallucinations","volume":"23","author":"Ramirez-Ruiz","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0445","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/pcn.12083","article-title":"Predicting treatment-seeking for visual hallucinations among Parkinson\u2019s disease patients","volume":"67","author":"Rana","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2025.04.023_bb0450","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/gps.5303","article-title":"Presence phenomena in parkinsonian disorders: phenomenology and neuropsychological correlates","volume":"35","author":"Reckner","year":"2020","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0455","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/gps.4929","article-title":"Visual hallucinations in dementia and Parkinson\u2019s disease: A qualitative exploration of patient and caregiver experiences","volume":"33","author":"Renouf","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0460","first-page":"51","article-title":"Psychological approaches to treating visual hallucinations in Lewy body dementias","volume":"164","author":"Rowley","year":"2023","journal-title":"FPOP Bulletin: Psychology of Older People."},{"key":"10.1016\/j.schres.2025.04.023_bb0465","article-title":"Patient perceptions and knowledge of Parkinson\u2019s disease and treatment (KnowPD)","volume":"3","author":"Salinas","year":"2020","journal-title":"Clin. Park Relat. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0470","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40266-016-0416-8","article-title":"Psychosis in Parkinson\u2019s disease: A review of etiology, phenomenology, and management","volume":"33","author":"Samudra","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.schres.2025.04.023_bb0475","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/08919887211018280","article-title":"Psychosis in Parkinson\u2019s disease: current treatment options and impact on patients and caregivers","volume":"34","author":"Segal","year":"2021","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"6","key":"10.1016\/j.schres.2025.04.023_bb0480","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1756285610389656","article-title":"Quetiapine in the treatment of psychosis in Parkinson\u2019s disease","volume":"3","author":"Shotbolt","year":"2010","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0485","article-title":"The phenomenology and neurobiology of visual distortions in schizophrenia: an update","volume":"12","author":"Silverstein","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2025.04.023_bb0490","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/schbul\/sbs034","article-title":"The treatment of hallucinations in schizophrenia spectrum disorders","volume":"38","author":"Sommer","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2025.04.023_bb0495","doi-asserted-by":"crossref","first-page":"fcac329","DOI":"10.1093\/braincomms\/fcac329","article-title":"Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson\u2019s disease","volume":"5","author":"Thomas","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.schres.2025.04.023_bb0500","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3109\/09638280903514705","article-title":"An interpretative phenomenological analysis of delusions in people with Parkinson\u2019s disease","volume":"32","author":"Todd","year":"2010","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.schres.2025.04.023_bb0505","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41401-020-0373-y","article-title":"Psychosis in Parkinson\u2019s disease and parkinsonism in antipsychotic-na\u00efve schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges","volume":"41","author":"Waddington","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.schres.2025.04.023_bb0510","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11065-018-9379-3","article-title":"Delusions in Parkinson\u2019s disease: a systematic review of published cases","volume":"28","author":"Warren","year":"2018","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.schres.2025.04.023_bb0515","doi-asserted-by":"crossref","first-page":"ONNS5189","DOI":"10.47795\/ONNS5189","article-title":"Hallucinations in Parkinson\u2019s disease: new insights into mechanisms and treatments","volume":"19","author":"Weil","year":"2020","journal-title":"Adv. Clin. Neurosci. Rehabil."},{"key":"10.1016\/j.schres.2025.04.023_bb0520","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/mds.23664","article-title":"Parkinson\u2019s disease: the quintessential neuropsychiatric disorder","volume":"26","author":"Weintraub","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0525","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.parkreldis.2019.10.018","article-title":"Increases in institutionalization, healthcare resource utilization, and mortality risk associated with Parkinson disease psychosis: retrospective cohort study","volume":"68","author":"Wetmore","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.schres.2025.04.023_bb0530","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2020.03.041","article-title":"A systematic review and meta-analysis of cognitive-behavioural informed psychological interventions for psychiatric inpatients with psychosis","volume":"222","author":"Wood","year":"2020","journal-title":"Schizophr. Res."},{"issue":"S4","key":"10.1016\/j.schres.2025.04.023_bb0535","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S1092852900017296","article-title":"Course, prognosis, and management of psychosis in Parkinson\u2019s disease: are current treatments really effective?","volume":"13","author":"Zahodne","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.schres.2025.04.023_bb0540","doi-asserted-by":"crossref","first-page":"fcz007","DOI":"10.1093\/braincomms\/fcz007","article-title":"Increased weighting on prior knowledge in Lewy body-associated visual hallucinations","volume":"1","author":"Zarkali","year":"2019","journal-title":"Brain Commun."},{"key":"10.1016\/j.schres.2025.04.023_bb0545","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/papt.12321","article-title":"Psychological interventions for people with Parkinson\u2019s disease in the early 2020s: where do we stand?","volume":"94","author":"Zarotti","year":"2021","journal-title":"Psychol. Psychother. Theory Res. Pract."},{"key":"10.1016\/j.schres.2025.04.023_bb0550","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/13546805.2023.2212151","article-title":"Neuropsychiatric features of Parkinson\u2019s disease in the era prior to the use of dopaminergic therapies","volume":"28","author":"Zhang","year":"2023","journal-title":"Cogn. Neuropsychiatry"},{"key":"10.1016\/j.schres.2025.04.023_bb0555","first-page":"3469706","article-title":"Prevalence and risk factors for minor hallucinations in patients with Parkinson\u2019s disease","volume":"2021","author":"Zhong","year":"2021","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.schres.2025.04.023_bb0560","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/mds.25389","article-title":"Risk factors for hallucinations in Parkinson\u2019s disease: results from a large prospective cohort study","volume":"28","author":"Zhu","year":"2013","journal-title":"Mov. Disord."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425001537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425001537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:30:12Z","timestamp":1774881012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996425001537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":112,"alternative-id":["S0920996425001537"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2025.04.023","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CBT for psychosis in Parkinson's disease: A framework for how and why","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2025.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}